Quadrant Capital Group’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-84
| Closed | -$527 | – | 2251 |
|
|
2025
Q1 | $527 | Buy |
+84
| New | +$527 | ﹤0.01% | 2651 |
|
|
2023
Q1 | – | Sell |
-212
| Closed | -$2.38K | – | 2775 |
|
|
2022
Q4 | $2.38K | Hold |
212
| – | – | ﹤0.01% | 2366 |
|
|
2022
Q3 | $2K | Hold |
212
| – | – | ﹤0.01% | 2407 |
|
|
2022
Q2 | $2K | Buy |
+212
| New | +$2K | ﹤0.01% | 2254 |
|
|
2022
Q1 | – | Sell |
-49
| Closed | -$1K | – | 2646 |
|
|
2021
Q4 | $1K | Buy |
+49
| New | +$1K | ﹤0.01% | 2372 |
|